An update on immune-based alpha-synuclein trials in Parkinson’s disease
Crossref DOI link: https://doi.org/10.1007/s00415-024-12770-x
Published Online: 2024-12-12
Published Print: 2025-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Alfaidi, Maha https://orcid.org/0009-0006-1380-9935
Barker, Roger A.
Kuan, Wei-Li
Text and Data Mining valid from 2024-12-12
Version of Record valid from 2024-12-12
Article History
Received: 24 September 2024
Revised: 24 October 2024
Accepted: 25 October 2024
First Online: 12 December 2024
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest.